Harpreet Dhaliwal
Corporate Officer/Principal chez VAXCYTE, INC.
Fortune : 1 M $ au 31/05/2024
Postes actifs de Harpreet Dhaliwal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VAXCYTE, INC. | Corporate Officer/Principal | 29/09/2021 | - |
Historique de carrière de Harpreet Dhaliwal
Anciens postes connus de Harpreet Dhaliwal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Biogen-Idec Pharmaceuticals, Inc.
 Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Corporate Officer/Principal | - | - |
| MEDIVATION INC | Corporate Officer/Principal | - | - |
Formation de Harpreet Dhaliwal
| Queen's University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Canada | 3 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Health Technology |
- Bourse
- Insiders
- Harpreet Dhaliwal
- Expérience
